The American College of Cardiology (ACC) and OpenEvidence are entering a strategic partnership to accelerate the translation of cardiovascular clinical guidance and research into clinical implementation at the point of care. By combining ACC’s leadership in cardiovascular science and education with OpenEvidence’s advanced generative artificial intelligence (AI) technology, clinicians will have access to the latest relevant and actionable medical evidence to support shared decision-making with their patients.

Young people in Scotland are experimenting with nicotine pouches and reporting adverse effects such as sickness and fainting, according to new research from the Scottish Centre for Social Research (ScotCen) published today in the journal Addiction.

About The Study: Within the studied participants, there were clear absolute benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors on kidney, hospitalization, and mortality outcomes irrespective of diabetes status and level of urine albumin to creatinine ratio.

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at American Society of Nephrology Kidney Week 2025 November 5–9.

A new study found that a rising number of premature deaths prevent many Americans from reaching the age of Medicare eligibility. From 2012 to 2022, deaths among adults ages 18 to 64 increased by 27%, according to an analysis of federal mortality data from all 50 states.